13F

Stock

Protalix BioTherapeutics, Inc.

PLX · held by 2 managers

Reported value

$49.8K

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$7.33K

Price effect on 2 books still in the name

Largest holder

$35K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC34.3K$35K−$5.15KCut−$6.44K
Finivi Inc.14.5K$14.8K−$2.18KCut−$2.18K

Positions as of Q3 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.